Parallax Volatility Advisers’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-86,000
Closed -$1.86M 2280
2023
Q4
$1.86M Buy
86,000
+72,500
+537% +$1.44M ﹤0.01% 1193
2023
Q3
$278K Buy
+13,500
New +$390K ﹤0.01% 1741
2021
Q3
Sell
-34,000
Closed -$1.93M 2162
2021
Q2
$1.93M Buy
+34,000
New +$2.4M ﹤0.01% 875
2019
Q4
Sell
-14,800
Closed -$2.08M 2609
2019
Q3
$2.08M Sell
14,800
-3,000
-17% -$502K ﹤0.01% 1123
2019
Q2
$3.26M Hold
17,800
﹤0.01% 885
2019
Q1
$2.83M Buy
17,800
+3,000
+20% +$434K ﹤0.01% 877
2018
Q4
$1.42M Hold
14,800
﹤0.01% 1197
2018
Q3
$2.09M Buy
+14,800
New +$2.28M ﹤0.01% 1008
2018
Q2
Sell
-20,000
Closed -$3.22M 3128
2018
Q1
$3.22M Buy
+20,000
New +$3.4M ﹤0.01% 638
2017
Q4
Sell
-50,100
Closed -$3.12M 4771
2017
Q3
$3.12M Buy
50,100
+100
+0.2% +$7.85K 0.01% 706
2017
Q2
$3.98M Buy
+50,000
New +$3.61M 0.01% 629

Other funds holding SAGE